Touyun Biotech Group Limited (1332.HK) HKSE

0.26

-0.015(-5.45%)

Updated at December 11 04:08PM

Currency In HKD

Valuation

Market Cap521.91M
Enterprise Value890.18M
P/E Ratio-15.22
PEG Ratio-0.2
Price/Sales Ratio6.46
Price/Book Ratio-6.89
Enterprise/Revenue9.78
Enterprise/EBITDA-33.57

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.25
Operating Margin-0.56

Management Effectiveness

Return On Assets-0.05
Return On Equity0.39

Income Statement

Revenue159.97M
Revenue/Share0.07
Gross Profit72.07M
EBITDA-27.92M
Net Income-88.11M
Diluted EPS-0.03

Balance Sheet

Total Cash11.53M
Total Cash/Share0.01
Total Debt400.72M
Total Debt/Equity-6.28
Current Ratio0.2
Book Value Per Share-0

Price History

52-Week Change45.95
52-Week High0.75
52-Week Low0.07
Moving Average 50 Days0.23
Moving Average 200 Days0.15

Statistics

Average Volume4.3M
Shares Outstanding2.81B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:4
Last Split DateAugust 12, 2019